Physicians Must Be “Fiduciary Stewards” To Rein In Rx Costs – Kaiser
Executive Summary
Pharmaceutical spending will only come under control if physicians take more responsibility for the financial impact of prescribing decisions, Kaiser Permanente Medical Group Associate Executive Director Sharon Levine, MD, said
You may also be interested in...
Bayer CME Institute Clients Include Kaiser, Veterans Health Administration
The Bayer Institute for Health Care Communications focuses its continuing medical education activities on enhancing clinician/patient communication.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials